Pregnancy outcome after TNF-α inhibitor therapy during the first trimester: a prospective multicentre cohort study (Q36125487)

12 August 2017

Pregnancy outcome after TNF-α inhibitor therapy during the first trimester: a prospective multicentre cohort study (English)

1 reference

multicenter clinical trial

12 August 2017

0 references

1 reference

Corinna Weber-Schoendorfer

1

1 reference

12 August 2017

Marc Oppermann

2

1 reference

12 August 2017

Evelin Wacker

3

1 reference

12 August 2017

Nathalie Bernard

4

1 reference

12 August 2017

network of French pharmacovigilance centres

5

1 reference

12 August 2017

Delphine Beghin

6

1 reference

12 August 2017

Benedikte Cuppers-Maarschalkerweerd

7

1 reference

12 August 2017

Jonathan L Richardson

8

1 reference

12 August 2017

Laura E Rothuizen

9

1 reference

12 August 2017

Alessandra Pistelli

10

1 reference

12 August 2017

Heli Malm

11

1 reference

12 August 2017

Georgios Eleftheriou

12

1 reference

12 August 2017

Debra Kennedy

13

1 reference

12 August 2017

Mine Kadioglu Duman

14

1 reference

12 August 2017

Reinhard Meister

15

1 reference

12 August 2017

Christof Schaefer

16

1 reference

12 August 2017

language of work or name

English

0 references

publication date

25 March 2015

1 reference

British Journal of Clinical Pharmacology

12 August 2017

1 reference

12 August 2017

80

1 reference

12 August 2017

4

1 reference

12 August 2017

727-739

1 reference

Anti-TNFα therapies are safe during pregnancy in women with inflammatory bowel disease: a systematic review and meta-analysis

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4594709

Safety of TNF-α inhibitors during IBD pregnancy: a systematic review

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4594709

Safety of anti-TNF agents during pregnancy and breastfeeding in women with inflammatory bowel disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4594709

Tumor necrosis factor-α inhibitor therapy and fetal risk: a systematic literature review

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4594709

Placental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4594709

Emerging data on the use of anti-tumor necrosis factor-alpha medications in pregnancy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4594709

Syndactyly: phenotypes, genetics and current classification

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4594709

VACTERL/VATER Association

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4594709

TNF-α and the development of the neonatal immune system: implications for inhibitor use in pregnancy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4594709

Anti-TNF therapies and pregnancy: outcome of 130 pregnancies in the British Society for Rheumatology Biologics Register

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4594709

European evidenced-based consensus on reproduction in inflammatory bowel disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4594709

A safety assessment of tumor necrosis factor antagonists during pregnancy: a review of the Food and Drug Administration database

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4594709

Placental transport of immunoglobulins: a clinical review for gastroenterologists who prescribe therapeutic monoclonal antibodies to women during conception and pregnancy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4594709

Using observational cohort data for studying drug effects on pregnancy outcome--methodological considerations

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4594709

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4594709

Paroxetine and congenital malformations: meta-Analysis and consideration of potential confounding factors

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4594709

TNF-alpha in pregnancy loss and embryo maldevelopment: a mediator of detrimental stimuli or a protector of the fetoplacental unit?

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4594709

Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4594709

Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD)

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4594709

Does the average drug exposure in pregnant women affect pregnancy outcome? A comparison of two approaches to estimate the baseline risks of adverse pregnancy outcome.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4594709

High rate of preterm birth in pregnancies complicated by rheumatoid arthritis

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4594709

Birth outcomes in women with inflammatory bowel disease: effects of disease activity and drug exposure

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4594709

Pregnancy outcome following gestational exposure to TNF-alpha-inhibitors: a prospective, comparative, observational study.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4594709

Limited risks of major congenital anomalies in children of mothers with IBD and effects of medications

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4594709

Safety of thiopurines and anti-TNF-α drugs during pregnancy in patients with inflammatory bowel disease.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4594709

The role of teratology information services in screening for teratogenic exposures: challenges and opportunities

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4594709

Case Report: Fatal case of disseminated BCG infection in an infant born to a mother taking infliximab for Crohn's disease

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4594709

Association of higher rheumatoid arthritis disease activity during pregnancy with lower birth weight: results of a national prospective study

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4594709

Do tumor necrosis factor inhibitors cause malformations in humans?

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4594709

Women with rheumatoid arthritis negative for anti-cyclic citrullinated peptide and rheumatoid factor are more likely to improve during pregnancy, whereas in autoantibody-positive women autoantibody levels are not influenced by pregnancy.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4594709

Statistical methods for estimating the probability of spontaneous abortion in observational studies--analyzing pregnancies exposed to coumarin derivatives

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4594709

Pregnancy outcome after methotrexate treatment for rheumatic disease prior to or during early pregnancy: a prospective multicenter cohort study

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4594709

Propensity Score Estimation With Boosted Regression for Evaluating Causal Effects in Observational Studies

21 October 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FBCP.12642

Tumor necrosis factor-alpha inhibition and VATER association: a causal relationship

21 January 2018

1 reference

12 December 2020

Pregnancy outcomes in women with rheumatoid arthritis in Washington State

1 reference

12 December 2020

Effects of an anti-TNF-alpha monoclonal antibody, administered throughout pregnancy and lactation, on the development of the macaque immune system

1 reference

12 December 2020

Treatment with tumor necrosis factor inhibitors and intravenous immunoglobulin improves live birth rates in women with recurrent spontaneous abortion

1 reference

12 December 2020

Treatment with adalimumab (Humira) and intravenous immunoglobulin improves pregnancy rates in women undergoing IVF

1 reference

12 December 2020

[Short communication about percentile values of body measures of newborn babies]

1 reference

12 December 2020

Etanercept concentrations in maternal serum, umbilical cord serum, breast milk and child serum during breastfeeding

1 reference

12 December 2020

High intra-uterine exposure to infliximab following maternal anti-TNF treatment during pregnancy

1 reference

12 December 2020

The distribution of congenital anomalies within the VACTERL association among tumor necrosis factor antagonist-exposed pregnancies is similar to the general population

1 reference

12 December 2020

Identifiers

DOI

10.1111/BCP.12642

1 reference

12 August 2017

1 reference

12 August 2017

1 reference